97381960 - VIVANI MEDICAL

Information

• Trademark
• 97381960

• Source

• Serial Number

  97381960

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth

• Filing Date

  April 26, 2022
  2 years ago

• Transaction Date

  February 22, 2024
  4 months ago

• Status Date

  February 07, 2024
  4 months ago

• Published for Opposition Date

  June 20, 2023
  a year ago

• Location Date

  August 15, 2023
  10 months ago

• Status Code

  730

• Current Location

  INTENT TO USE SECTION

  Employee Name

  GRYGIEL, JONATHAN C

• Attorney Docket Number

  S-14

  Attorney Name

  Scott B. Dunbar

  Law Office Assigned Location Code

  N20

• Owners

  • Second Sight Medical Products, Inc.

Case File Statements

• GS0051: Implantable drug delivery devices having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; Implantable drug delivery devices having a drug reservoir and a nanoporous membrane sold preloaded with a therapeutic agent, namely, an injectable device for time release of the therapeutic agent for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy
• GS0011: Nanoporous membranes used in drug delivery devices for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; Nanoporous membranes used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant where the drug reservoir dictates the duration of therapy delivered from the drug implant
• GS0101: Nanoporous membranes used in drug delivery devices for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nanoporous membranes used for improving medication adherence in the treatment of chronic disease, in particular, metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases, namely, diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases, namely, Alzheimer's, dementia, sociopathy or psychopathy, and other diseases treated with small drug molecules; Electrotherapy medical devices for electrical nerve stimulation and recording, namely, neurostimulation devices, stimulating and recording electrode implants, visual prostheses and visual cortical implants; Cortical electrodes integrally attached to implantable cortical stimulators and other systems, namely, electrodes, stimulators, headpieces, and wearable video processors for the treatment of blindness; Surgical apparatus and instruments for the treatment of blindness; Medical apparatus and instruments for use in surgery for the treatment of blindness; Medical devices for the treatment of blindness
• D10000: "MEDICAL"

Case File Event Statements

• 2/21/2024 - 4 months ago

  23 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 2/9/2024 - 4 months ago

  22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 2/7/2024 - 4 months ago

  21 - SOU EXTENSION 1 GRANTED Type: EX1G

• 2/7/2024 - 4 months ago

  20 - SOU EXTENSION 1 FILED Type: EXT1

• 2/7/2024 - 4 months ago

  19 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 8/15/2023 - 10 months ago

  18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 6/20/2023 - a year ago

  17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/20/2023 - a year ago

  16 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/31/2023 - a year ago

  15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/18/2023 - a year ago

  14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/18/2023 - a year ago

  13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 5/18/2023 - a year ago

  12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 5/18/2023 - a year ago

  11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 5/18/2023 - a year ago

  10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 5/12/2023 - a year ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/11/2023 - a year ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/11/2023 - a year ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/14/2023 - a year ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 2/14/2023 - a year ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/14/2023 - a year ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/13/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 5/2/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/29/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP